ArticleScientific reports2025
Sildenafil reduced neuroinflammation and improved white matter injury in a rat model of term neonatal hypoxic-ischemic encephalopathy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neonatal Hypoxic-Ischemic Encephalopathy: From the Limitations of Therapeutic Hypothermia to Precision Intervention.Drug design, development and therapy · 2026Review
- Neuroimmune responses in neonatal hypoxic-ischemic encephalopathy: cellular roles, crosstalk, and therapeutic opportunities.Frontiers in pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Neonatal hypoxic-ischemic encephalopathy (HIE) can cause lifelong neurological impairments. In its tertiary phase, ongoing neuroinflammation creates a toxic environment that promotes neuronal and oligodendrocyte loss. Sildenafil has shown neuroprotective effects in adult models by reducing inflammation and supporting oligodendrocyte survival, but its role in HIE remains unexplored. This study investigated the effects of sildenafil on neuroinflammation and white matter injury in a rat model of term neonatal HIE. Hypoxia-ischemia (HI) was induced in postnatal day 10 (P10) male Long-Evans rats via a left carotid ligation followed by 2 h of hypoxia (8% oxygen). Pups were randomized to receive oral sildenafil or vehicle starting 12 h post-HI, twice daily for 7 days. White matter integrity (corpus callosum and external capsule), oligodendrocyte presence, and glial activation were assessed by histology and immunohistochemistry. Inflammatory markers were measured by enzyme-linked immunosorbent assay (ELISA), and signaling pathways were examined by Western blot. Outcomes were compared to sham and untreated HI controls. HI significantly increased number of GFAP + reactive astrocytes and Iba1 + microglia, alongside elevated TNFα and IL-1β levels. Thickness of the corpus callosum and left external capsule was reduced. Sildenafil treatment - particularly at medium and high doses - attenuated astrocytes and microglia activation, restored microglial morphology, and normalized cytokine expression. White matter thickness was significantly improved, with increased numbers of total Olig2 + and mature CC1 + oligodendrocytes. Mechanistically, sildenafil restored p-AKT levels, which suggests involvement of the PI3K/AKT/mTOR pathway. Sildenafil significantly reduced neuroinflammation, improved white matter integrity, and supported oligodendrocyte recovery after neonatal HI. These findings highlight the potential of sildenafil as a neurorestorative therapy during the tertiary phase of injury in neonatal HIE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.